RPK

R-Pharm is a leading international pharmaceutical company headquartered in Russia, specializing in the development, manufacturing, and commercialization of high-tech medicines. The company operates across a broad spectrum of therapeutic areas, including oncology, hematology, immunology, and infectious diseases. R-Pharm gained significant global attention for its role in manufacturing the Sputnik V COVID-19 vaccine and developing its own antiviral treatments like Coronavir. With a robust infrastructure of R&D centers and manufacturing sites, the company provides a comprehensive suite of services from drug discovery to large-scale production. R-Pharm maintains numerous strategic partnerships with global pharmaceutical giants to localize the production of innovative therapies for the Eurasian market.